Kyoko Tanaka

Title: Kyoko Tanaka: Innovator in Immunological Assays

Introduction

Kyoko Tanaka is a prominent inventor based in Naka-gun, Japan. She has made significant contributions to the field of immunology, particularly through her innovative work on monoclonal antibodies. Her research has the potential to impact medical diagnostics and treatment strategies.

Latest Patents

Kyoko Tanaka holds a patent for an "Anti-human soluble fibrin monoclonal antibody and immunological assay method using the antibody." This invention focuses on a monoclonal antibody that specifically recognizes a conformation-changed site in the C-terminal region of the Aα-chain of soluble fibrin. This soluble fibrin is formed through thrombin digestion of fibrinogen. The patent also includes a hybridoma that produces the antibody, an immunological assay method employing the antibody, and a method for evaluating hypercoagulability in a test sample by measuring the soluble fibrin level. This innovative approach allows for the specific detection of soluble fibrin that has not been acted upon by plasmin, reflecting initial hypercoagulability.

Career Highlights

Kyoko Tanaka is associated with Daiichi Pure Chemicals Co., Ltd., where she continues to advance her research in immunology. Her work has garnered attention for its potential applications in clinical settings, particularly in diagnosing conditions related to blood coagulation.

Collaborations

Kyoko has collaborated with notable colleagues, including Masanao Matsuo and Hiroyuki Ebinuma. These collaborations have contributed to the development and refinement of her innovative research.

Conclusion

Kyoko Tanaka's contributions to the field of immunology through her patented inventions highlight her role as a leading inventor. Her work not only advances scientific knowledge but also has practical implications for medical diagnostics and patient care.